Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 1
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
1| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8334265 | SCENESSEafamelanotide | use | Jan 2033 |
| Product | Exclusivity | Until |
|---|---|---|
| SCENESSEAFAMELANOTIDE | ODE-270 Orphan drug | Oct 2026 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| SCENESSE | afamelanotide | implant, subcutaneous | 73372-0116NDA |
Compare
Other companies listing afamelanotide
- Synergy Health AST, LLC11 sites · 24 NDC
Enquiry
Common questions
- Is CLINUVEL INC. FDA approved?
- CLINUVEL INC. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does CLINUVEL INC. make?
- 1 product is listed under CLINUVEL INC. in the openFDA NDC Directory, most often as implant. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.